World's Best Scientists 2026 revealed!
Award Badge
Medicine
Sweden
2023

D-Index & Metrics

Medicine

D-Index
118
Citations
89074
World Ranking
3962
National Ranking
80

Björn Dahlöf publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Björn Dahlöf sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 532 publications — 63rd percentile

63% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Björn Dahlöf D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Björn Dahlöf sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 118 D-Index — 80th percentile

80% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Research.com Recognitions

  • 2023 - Research.com Medicine in Sweden Leader Award

Overview

Björn Dahlöf is affiliated with Sahlgrenska University Hospital in Sweden, focusing on their medical and clinical research activities there.

There is no available data regarding recent papers published by Dahlöf, as well as no records of frequent co-authors or common publication venues.

Information about Dahlöf's work in terms of specific fields of study, subfields, or main research topics is not available.

Similarly, there is no information pertaining to book publications or awards received by Dahlöf.

The profile therefore primarily identifies Björn Dahlöf's institutional affiliation without further details on research output or scientific contributions at this time.

Best Publications

  • Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial

    Lennart Hansson;Alberto Zanchetti;S George Carruthers;Björn Dahlöf

  • Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol.

    Björn Dahlöf;Richard B Devereux;Sverre E Kjeldsen;Stevo Julius

  • Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial—Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial

    Peter S Sever;Björn Dahlöf;Neil R Poulter;Hans Wedel

  • Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial

    Björn Dahlöf;Peter S Sever;Neil R Poulter;Hans Wedel

  • Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial

    Lennart Hansson;Lars H Lindholm;Leo Niskanen;Jan Lanke

  • Benazepril plus Amlodipine or Hydrochlorothiazide for Hypertension in High-Risk Patients

    Kenneth Jamerson;Michael A. Weber;George L. Bakris;Björn Dahlöf

  • Morbidity and mortality in the Swedish Trial in Old Patients with Hypertension (STOP-Hypertension)

    B. Dahlöf;L. Hansson;L.H. Lindholm;B. Scherstén

  • Prognostic significance of visit-to-visit variability, maximum systolic blood pressure, and episodic hypertension.

    Peter M Rothwell;Sally C Howard;Eamon Dolan;Eoin O'Brien

  • Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol.

    Lars H Lindholm;Hans Ibsen;Björn Dahlöf;Richard B Devereux

  • Randomised trial of old and new antihypertensive drugs in elderly patients: cardiovascular mortality and morbidity the Swedish Trial in Old Patients with Hypertension-2 study.

    Lennart Hansson;Lars H Lindholm;Tord Ekbom;Björn Dahlöf

  • Guidelines for the management of atrial fibrillation

    A. John Camm;Paulus Kirchhof;Gregory Y H Lip;Ulrich Schotten

  • Reversal of left ventricular hypertrophy in hypertensive patients. A metaanalysis of 109 treatment studies.

    Björn Dahlöf;Kjell Pennert;Lennart Hansson

  • Randomised trial of effects of calcium antagonists compared with diuretics and β-blockers on cardiovascular morbidity and mortality in hypertension: the Nordic Diltiazem (NORDIL) study

    Lennart Hansson;Thomas Hedner;Per Lund-Johansen;Sverre Erik Kjeldsen

  • Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke

    Ralph L. Sacco;Hans-Christoph Diener;Salim Yusuf;Daniel Cotton

  • Angiotensin II receptor blockade reduces new-onset atrial fibrillation and subsequent stroke compared to atenolol: The Losartan Intervention For End point reduction in hypertension (LIFE) study

    Kristian Wachtell;Mika Lehto;Eva Gerdts;Michael H. Olsen

  • Prognostic significance of left ventricular mass change during treatment of hypertension

    Richard B Devereux;Kristian Wachtell;Eva Gerdts;Krister K. Boman

  • Telmisartan to prevent recurrent stroke and cardiovascular events.

    Salim Yusuf;Salim Yusuf;Hans-Christoph Diener;Ralph L. Sacco;Daniel Cotton

  • Effects of β blockers and calcium-channel blockers on within-individual variability in blood pressure and risk of stroke

    Peter M Rothwell;Sally C Howard;Eamon Dolan;Eoin O'Brien

  • Regression of electrocardiographic left ventricular hypertrophy during antihypertensive treatment and the prediction of major cardiovascular events.

    Peter M. Okin;Richard B. Devereux;Sverker Jern;Sverre E. Kjeldsen

  • Prevention of Coronary and Stroke Events with Atorvastatin in Hypertensive Patients who have Average or Lower-than-Average Cholesterol Concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial— Lipid Lowering Arm (ASCOT-LLA): A Multicentre Randomised Controlled Trial

    Peter S Sever;Björn Dahlöf;Neil R Poulter;Hans Wedel

Frequent Co-Authors

Richard B. Devereux
Richard B. Devereux Cornell University
Sverre E. Kjeldsen
Sverre E. Kjeldsen University of Oslo
Kristian Wachtell
Kristian Wachtell Cornell University
Markku S. Nieminen
Markku S. Nieminen University of Helsinki
Peter M. Okin
Peter M. Okin Cornell University
Stevo Julius
Stevo Julius University of Michigan–Ann Arbor
Hans Wedel
Hans Wedel University of Gothenburg
Peter S. Sever
Peter S. Sever Imperial College London
Neil R. Poulter
Neil R. Poulter Imperial College London
Ulf de Faire
Ulf de Faire Karolinska Institute

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a career in Medicine opens up a diverse range of online degree options and pathways. For those interested in the growing field of nutrition and wellness, an online nutrition degree can lead to roles in clinical settings, public health, or research.

For future healthcare leaders, many choose cahme accredited online healthcare administration programs to gain critical management and leadership skills. These programs offer flexibility and industry-recognized credentials.

Registered nurses looking to advance their education may benefit from best online rn to bsn programs without clinical requirements, which make it easier for working professionals to complete their degrees without additional on-site training.

Meanwhile, practicing nurses aiming for the highest level in clinical nursing practice can consider a 1 year dnp program online to quickly achieve their doctorate and step into advanced roles.

Each of these pathways provides online flexibility and varying clinical requirements, making it easier than ever to pursue a rewarding future in medicine and healthcare.

Best Scientists Citing Björn Dahlöf

Trending Scientists

Recently Published Articles